Please login to the form below

Not currently logged in
Email:
Password:

cediranib

This page shows the latest cediranib news and features for those working in and with pharma, biotech and healthcare.

AZ withdraws EU filing for ovarian cancer drug cediranib

AZ withdraws EU filing for ovarian cancer drug cediranib

AZ withdraws EU filing for ovarian cancer drug cediranib. Maintains cediranib’ s value as a combination therapy despite EMA information request. ... While its role as a monotherapy is ended, cediranib remains an important component of AZ's combination

Latest news

  • ASCO: AZ’s ovarian cancer combination aces trial ASCO: AZ’s ovarian cancer combination aces trial

    ASCO: AZ’ s ovarian cancer combination aces trial. Olaparib/cediranib combo demonstrates progression-free survival of 17.7 months. ... Combining olaparib and cediranib may herald the beginning of treatments that avoid chemotherapy in some patients with

  • Glioblastomas - a personalised future? Glioblastomas - a personalised future?

    Many agents have been unsuccessful. One of these, the pan-VEGF inhibitor cediranib, was discontinued at phase 3 due to disappointing results from pivotal studies.

  • Extending the arsenal

    It is also only one of a handful of therapies — along with aflibercept (Regeneron Pharmaceuticals), brivanib alaninate (Bristol-Myers Squibb) and cediranib (AstraZeneca) — in late-stage clinical trials for this type

  • AZ's Recentin trial disappoints

    AZ's Recentin trial disappoints. AstraZeneca's colorectal cancer drug, Recentin (cediranib), has failed to match Roche's Avastin (bevacizumab) in a phase II/III comparison study. ... AstraZeneca (AZ) has announced that its colorectal cancer drug,

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics